The ‘Biggest’ Dealmakers Of 2023 Were Not The Busiest

 
• By Joseph Haas
  
Deal making concept
The year’s biggest dealmakers – Pfizer, Bristol Myers Squibb and AbbVie – were not among the five busiest based on a review of dealmaking data • Source: Shutterstock

More from Deal-Making

More from In Vivo